⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Rinpharm and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Rinpharm
↗Moscow, Russia
Rinpharm is a Russian pharmaceutical company focused on the sale, promotion, and development of pharmaceutical products. The company specializes in providing a full range of services for bringing medicinal products to the Russian market, including regulatory approval, pharmaceutical development, and commercial production in cooperation with contract manufacturing organizations.
Their portfolio includes niche and orphan drugs, with a particular emphasis on generics and antiepileptic medications. Rinpharm operates as a marketing authorization holder and actively engages in pharmacovigilance and distribution within the Russian Federation and the Eurasian Economic Union (EAEU).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics and Orphan Drugs
SIZE & FINANCIALS
Employees:51-200
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmproject (Contract Manufacturer)
COMPETITION
Position:Niche Player
Competitors:R-Pharm, Pharmasyntez, Biocad, Geropharm
LINKS
Website:rinpharm.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rinpharm. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.